Literature DB >> 23769458

Practice patterns among U.S. gastroenterologists regarding endoscopic management of Barrett's esophagus.

Mandeep Singh1, Neil Gupta, Srinivas Gaddam, Gokulakrishnan Balasubramanian, Sachin Wani, Preetika Sinh, Kamran Aghaie, April D Higbee, Amit Rastogi, Vijay Kanakadandi, Ajay Bansal, Prateek Sharma.   

Abstract

BACKGROUND: Endoscopic management of Barrett's esophagus (BE) has evolved over the past decade; however, the practice patterns for managing BE among gastroenterologists remain unclear.
OBJECTIVE: To assess practice patterns for management of BE among gastroenterologists working in various practice settings.
DESIGN: A random questionnaire-based survey of practicing gastroenterologists in the United States. The questionnaire contained a total of 10 questions pertaining to practice setting, physician demographics, and strategies used for managing BE.
SETTING: Survey of gastroenterologists working in various practice settings. INTERVENTION: Questionnaire. MAIN OUTCOME MEASUREMENTS: Practice patterns for endoscopic imaging and management of BE.
RESULTS: The response rate was 45% (236/530). The majority (85%) were gastroenterologists in community practice, 72% were aged 41 to 60 years, 80% had >10 years of experience, and 81% had attended postgraduate courses and/or seminars on BE management. A total of 78% did not use the Prague C & M classification, and about a third used advanced endoscopic imaging routinely (37%) or in selected cases (31%). For nondysplastic BE, 86% practiced surveillance, 12% performed ablation, and 3% did no intervention. For BE with low-grade dysplasia, 56% practiced surveillance, 26% performed endoscopic ablation in all low-grade dysplasia cases, and 18% performed endoscopic ablation in only selected patients with low-grade dysplasia. The majority of respondents (58%) referred their patients with high-grade dysplasia to centers with BE expertise, 13% performed endoscopic ablation in all patients with high-grade dysplasia, 25% performed endoscopic ablation in selected cases only, and 3% referred these patients for surgery. The most frequently used endoscopic eradication therapy was radiofrequency ablation (39%) followed by EMR (17%). LIMITATIONS: The sample may be unrepresentative, participation in the study was voluntary, and responses may be skewed toward following the guidelines.
CONCLUSION: Results from this survey show that the majority of practicing gastroenterologists in the United States practice surveillance endoscopy in patients with nondysplastic BE and provide endoscopic therapy for those with high-grade dysplasia. The Prague C & M classification and advanced imaging techniques are used by less than a third of gastroenterologists. Practice patterns did not appear to be affected by respondent age or duration of clinical practice.
Copyright © 2013 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  ACG; AGA; ASGE; American College of Gastroenterology; American Gastroenterological Association; American Society for Gastrointestinal Endoscopy; BE; Barrett's esophagus; EAC; HGD; LGD; Prague C & M; Prague circumference (C) and maximum length (M); esophageal adenocarcinoma; high-grade dysplasia; low-grade dysplasia

Mesh:

Year:  2013        PMID: 23769458     DOI: 10.1016/j.gie.2013.05.002

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  14 in total

1.  From Prague to Seattle: Improved Endoscopic Technique and Reporting Improves Outcomes in Patients with Barrett's Esophagus.

Authors:  J Brown; P Sharma
Journal:  Dig Dis Sci       Date:  2016-01       Impact factor: 3.199

2.  The essence of management of Barrett's esophagus.

Authors:  Kenneth K Wang
Journal:  Gastrointest Endosc       Date:  2013-11       Impact factor: 9.427

3.  The global prevalence of Barrett's esophagus: A systematic review of the published literature.

Authors:  Inês Marques de Sá; Pedro Marcos; Prateek Sharma; Mário Dinis-Ribeiro
Journal:  United European Gastroenterol J       Date:  2020-07-06       Impact factor: 4.623

4.  Shining a White Light on Barrett's Esophagus: What Does the BING Classification Bring?

Authors:  Shajan Peter
Journal:  Dig Dis Sci       Date:  2017-10       Impact factor: 3.199

Review 5.  How Should We Report Endoscopic Results in Patient's with Barrett's Esophagus?

Authors:  Venkata Subhash Gorrepati; Prateek Sharma
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

6.  Adherence to therapy for Barrett's esophagus-associated neoplasia.

Authors:  Lisa Cassani; James C Slaughter; Patrick Yachimski
Journal:  United European Gastroenterol J       Date:  2015-05-05       Impact factor: 4.623

7.  A Survey of Expert Practice and Attitudes Regarding Advanced Imaging Modalities in Surveillance of Barrett's Esophagus.

Authors:  Jorge D Machicado; Samuel Han; Rena H Yadlapati; Violette C Simon; Bashar J Qumseya; Shahnaz Sultan; Vladimir M Kushnir; Sri Komanduri; Amit Rastogi; V Raman Muthusamy; Rehan Haidry; Krish Ragunath; Rajvinder Singh; Hazem T Hammad; Nicholas J Shaheen; Sachin Wani
Journal:  Dig Dis Sci       Date:  2018-09-03       Impact factor: 3.199

8.  Endoscopic mucosal resection or ablation for Barrett's esophagus containing high grade dysplasia: agreement strongest among expert gastroenterologists.

Authors:  Ashley Canipe; James Slaughter; Patrick Yachimski
Journal:  Endosc Int Open       Date:  2014-09-26

Review 9.  Ablative therapy for esophageal dysplasia and early malignancy: focus on RFA.

Authors:  Rebecca Tuttle; Steven J Nurkin; Steven N Hochwald
Journal:  Biomed Res Int       Date:  2014-07-21       Impact factor: 3.411

10.  ESGE Survey: worldwide practice patterns amongst gastroenterologists regarding the endoscopic management of Barrett's esophagus.

Authors:  Simon J Dunn; Laura J Neilson; Cesare Hassan; Prateek Sharma; Claire Guy; Colin J Rees
Journal:  Endosc Int Open       Date:  2016-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.